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Downregulation of Melanin Synthesis by Haginin A
and Its Application to In Vivo Lightening Model
Jin Hee Kim1, Seung Hwa Baek1, Dong Hyun Kim1, Tae Young Choi2, Tae Jin Yoon3, Jae Sung Hwang4,
Mee Ree Kim5, Ho Jeong Kwon6 and Choong Hwan Lee7
Haginin A, an isoflav-3-ens isolated from the branch of Lespedeza cyrtobotrya, is almost unknown. Here, we
report that haginin A exhibits a strong hypopigmentary effect in Melan-a cells and significantly inhibits melanin
synthesis. Haginin A shows potent inhibitory effects with an IC50 (half-maximal inhibitory concentration) value
of 5.0 mM on mushroom tyrosinase activity, and functioned as a noncompetitive inhibitor. Also, haginin A
decreased microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related protein-1
(TRP-1) protein production. To identify the signaling pathway of haginin A, the ability of haginin A to influence
extracellular signal-regulated protein kinase (ERK) and Akt/protein kinase B (PKB) activation was investigated.
Apparently, haginin A induced ERK and Akt/PKB in a dose-dependent manner. In addition, the specific inhibition
of the ERK and the Akt/PKB signaling pathways by PD98059 and LY294002, respectively, increased melanin
synthesis. Furthermore, haginin A decreased UV-induced skin pigmentation in brown guinea-pigs. Also, haginin
A presented remarkable inhibition on the body pigmentation in the zebrafish model system and decreased
tyrosinase activity. Together, haginin A is an effective inhibitor of hyperpigmentation caused by UV irradiation or
by pigmented skin disorders through downregulation via ERK and Akt/PKB activation, MITF, and also by the
subsequent downregulation of tyrosinase and TRP-1 production.
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INTRODUCTION
In mammals, melanin production is restricted to the melano-
cytes of the skin, hair follicles, and pigment epithelium in
the retina. Three melanocyte-specific enzymes, tyrosinase,
tyrosinase-related protein (TRP)-1, and TRP-2 are involved in
melanogenesis, in which tyrosine is converted into melanin
pigments (Kobayashi et al., 1994; Ando et al., 1999). In
particular, tyrosinase plays a key role in this process, because
it catalyzes two rate-limiting reactions involved in melano-
genesis: the hydroxylation of tyrosine to 3,4-dihydroxyphe-
nylalanine (DOPA), and the oxidation of DOPA, which
results in the formation to dopaquinone (Hearing and
Tsukamoto, 1991).
Several of the known natural melanin synthesis inhibitors,
including arbutin and kojic acid, have already been the focus of
studies, and are currently being utilized as cosmetic additives
(Fujimoto et al., 1998). However, it is clearly necessary to find
safer and more effective skin-whitening agents, due to the
carcinogenic potential of kojic acid, not to mention its weak
whitening effects. A great deal of attention has continuously
focused on the application of natural products in the cosmetics
industry (Shimizu et al., 2003; Park et al., 2004). The signaling
pathways responsible for the regulation of melanocyte differ-
entiation have yet to be clearly elucidated, although several
important advances have been made in this regard.
Microphthalmia-associated transcription factor (MITF),
characterized by an essential basic helix–loop–helix leucine
zipper structure, is currently believed to regulate melanocyte
pigmentation, proliferation, and survival (Steingrimsson et al.,
1994). In addition, MITF has been shown to effectively
transactivate the tyrosinase, TRP-1, and TRP-2 melanogenic
genes in vitro, via binding to an M-box motif that is present
in the promoters of these genes (Yasumoto et al., 1997;
Bertolotto et al., 1998). The use of molecules that can trigger
the signaling pathways upstream of these key melanocyte
genes might provide a useful tool in furthering our current
understanding of melanocyte differentiation.
In this study, we have screened a large number of plant
extracts using Melan-a cells and we found that haginin A,
which had been isolated from the Lespedeza cyrtobotrya
branch, exerted a profound inhibitory effect on the synthesis
of melanin. However, the biological effects of haginin A
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are comparatively unknown. Therefore, we investigated the
effects of haginin A on melanogenesis in Melan-a cells with
regard to extracellular signal-regulated protein kinase (ERK)
and Akt/protein kinase B (PKB) pathway activation.
RESULTS
Inhibitory effects of haginin A on tyrosinase activity and
melanin biosynthesis of Streptomyces bikiniensis
The structure of haginin A is shown in Figure 1. The effects of
haginin A on tyrosinase activity were determined via mushroom
tyrosinase assays. The IC50 (half-maximal inhibitory concentra-
tion) values of a variety of tyrosinase inhibitors were determined
using L-tyrosine as a substrate. Haginin A, arbutin, and kojic
acid were all shown to inhibit mushroom tyrosinase, and all of
these compounds exerted their effects in a dose-dependent
manner. Among these, haginin A was determined to exert the
most profound inhibitory effects on mushroom tyrosinase
(IC50¼5mM), followed by kojic acid (IC50¼ 50.1mM) and
arbutin (IC50¼ 58.4mM) (Table 1). Moreover, haginin A was
10-fold more potent than kojic acid in its inhibitory effects on
tyrosine oxidation. These inhibitory effects on tyrosinase activity
and subsequent melanin formation were also confirmed in
S. bikiniensis. Apparently, haginin A inhibited the biosynthesis
of melanin in S. bikiniensis (Table 1). We also conducted a
kinetic study of the catalysis of L-tyrosine oxidation by mush-
room tyrosinase in the presence of haginin A (Figure 2). Haginin
A was shown to reduce the maximal velocity (Vmax) of
mushroom tyrosinase activity, but no significant effects on the
Km values were observed. As summarized in Table 2, the Vmax
value (DA490 per minute) of mushroom tyrosinase activity was
3.6102, and the Km value was 0.2mM L-tyrosine. The
mushroom tyrosinase activity in the presence of haginin A at
0.87 and 1.67mM demonstrated identical Km values (0.2mM)
and exhibited 2.6102 and 1.7 102, respectively, as Vmax
values. Therefore, haginin A was clearly implicated as a non-
competitive inhibitor of the mushroom enzyme, with Ki values
of 2.17±0.48 and 1.48±0.41mM. The profound inhibitory
activity on the oxidase activities of mushroom tyrosinase by
haginin A strongly suggests that haginin A might be a potential
candidate for development of a skin-whitening agent.
Haginin A exerts strong hypopigmentary effects on Melan-a
cells
To investigate whether haginin A exerts cytotoxic effects
on Melan-a cells, we applied haginin A to these cells at
concentrations of 0.4–13.3mM for 4 days, then assessed cell
viability via crystal violet assays. Melan-a cells are syngeneic,
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Figure 1. The structure of haginin A.
Table 1. Inhibitory effects on mushroom tyrosinase
activity and melanin formation in Streptomyces
bikiniensis
Mushroom
tyrosinase
S. bikiniensis NRRL B-1049
inhibition zone (mm)
Compound IC50 (lM) 30 lg 20lg 10lg
Haginin A 5.0±0.013 42 35 23
Arbutin 58.4±0.017 0 0 0
Kojic acid 50.1±0.015 0 0 0
r-Methylphenol 120.0±0.020 35 25 15
IC50, half-maximal inhibitory concentration.
Tyrosinase was preincubated with test substances at 25 1C for 10min prior
to incubation with L-tyrosine for 30min and the absorbance was determined
at 490nm. Each value represents the mean±SD of three experiments.
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Figure 2. Lineweaver–Burk plot of mushroom tyrosinase in the presence of
haginin A. Data are expressed as mean values of 1/V, inverse of the increase
in absorbance at 490 nmminute1 (DA490 per minute), and means of three
independent tests with different concentrations of L-tyrosine used as a
substrate. Haginin A concentrations as an inhibitor were as follows:
&, 0.87 mM; n, 1.67 mM; K, control.
Table 2. Kinetic parameters of mushroom tyrosinase
in the presence of haginin A
Compound Km (M)
Vmax
(DA490 per min) Ki (M)
None 2.03 104 3.6 102 —
Haginin A 2.03 104
(8.67107 M) 2.6 102 2.17±0.48106
(1.67106 M) 1.7 102 1.48±0.41106
Vmax, maximal velocity.
The kinetic parameters were obtained with L-tyrosine as a substrate using
the Lineweaver–Burk plot shown in Figure 2. Km and Ki values are
represented as the molar concentration and Vmax values are expressed as
the increases in absorbance at 490 nm.
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are associated with the B16 melanoma and its sublines,
provide an excellent parallel non-tumorigenic cell line for
examining the malignancy of melanoma, and have similar
phenotype as the primary mouse melanocyte (Bennett et al,
1987). As is shown in Figure 3a, haginin A exerted no
cytotoxic effects on the Melan-a cells at the tested con-
centrations. To characterize the effects of haginin A, we
measured melanin contents of Melan-a and HEMn (human
epidermal melanocytes) cells. We used 1-phenyl-2-thiourea
(PTU) and kojic acid as positive controls in these studies
because of their known inhibitory effects on melanin
synthesis. The levels of melanin in Melan-a and HEMn
cells were determined to have been significantly reduced as
a result of haginin A treatment. As shown in Table 3, the
concentration of haginin A required for a 50% inhibition in
Melan-a and HEMn cells was found to be approximately 3.3
and 2.7 mM, respectively. However, kojic acid was shown
to exert no detectable effects on melanin production in
Melan-a and HEMn cells.
Melanin levels were significantly reduced in a dose-
dependent manner by haginin A treatment in Melan-a cells
(Figure 3b). In addition, haginin A at the same concen-
trations also decreased tyrosinase activity in Melan-a cells
(Figure 3c). These findings suggest that haginin A regulates
tyrosinase and subsequently suppresses melanin synthesis in
Melan-a cells.
Haginin A reduces tyrosinase protein levels and reduces MITF
protein levels
Melanogenesis is known to be controlled by an enzymatic
cascade, which is regulated at the levels of tyrosinase,
TRP-1, and TRP-2 (Gaggioli et al., 2003). The amounts of
those enzymes in the cells during the reduced pigmentation
elicited by haginin A were determined via western blot
analysis. Haginin A suppressed the expression levels of
tyrosinase and TRP-1 protein expression in Melan-a cells,
whereas there was no effect on TRP-2 levels in these cells
(Figure 4).
In particular, the induction level of tyrosinase was higher
than that of TRP-1. The amount of TRP-2 remained constant
throughout the course of the experiment, thus working as an
appropriate internal control.
MITF is reported to bind to the M-box within the tyrosinase
promoter and thus to regulate tyrosinase gene expression
(Bentley et al., 1994). As MITF controls tyrosinase protein
levels, we examined the level of MITF protein after haginin A
treatment. As shown in Figure 5a, MITF protein levels were
reduced in a dose-dependent manner. Since a decreased
MITF gene expression may be responsible for a diminished
level of MITF protein, we next examined whether haginin A
has an effect on MITF transcription.
Reverse transcription PCR assays using MITF-specific
primers produced a 366 bp fragment corresponding to the
MITF mRNA. However, we did not observe any signi-
ficant change of the level of this PCR fragment in haginin
A-treated cells (Figure 5b), whereas the levels of MITF
protein reduced significantly (Figure 5a). Accordingly, we
suggest that the MITF protein reduction by haginin A may
be due to MITF degradation, not to suppression of MITF gene
expression.
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Figure 3. Effects of haginin A on melanogenesis of Melan-a cells. The
cells were cultured with 0.4–6.6 mM of haginin A for 4 days. (a) Cytotoxicity,
(b) melanin contents, and (c) tyrosinase activity were measured in Melan-a
cells, as described in Materials and Methods. The results are averages
of triplicate experiments, and the data are expressed as means±SD.
Table 3. Effects of haginin A, PTU, and kojic acid on
melanin production of Melan-a and HEMn cells
Melanin synthesis Cytotoxicity
IC50 (lM) LD50 (lM)
Compound Melan-a HEMn Melan-a HEMn
Haginin A 3.3 2.7 14.5 11.8
PTU 6.6 8.6 4200 4200
Kojic acid 4200 4200 4200 4200
IC50, half-maximal inhibitory concentration; LD50, dose lethal to 50% of
animals tested; PTU, 1-phenyl-2-thiourea.
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Haginin A induces phosphorylation of ERK and Akt/PKB in
Melan-a cells
To elucidate the mechanisms underlying the hypopigmentary
effects exerted by haginin A, we attempted to characterize the
changes in melanogenesis-related signals induced by haginin A
via western blot analysis. Furthermore, we examined whether
haginin A is able to influence ERK and/or Akt/PKB activation. As
shown in Figure 6, haginin A was shown to elicit ERK phosphory-
lation, and this effect was exerted in a dose-dependent manner.
Also, phosphorylation of Akt/PKB was much more activated.
We also investigated events upstream of ERK and found that
haginin A stimulated the phosphorylation of MEK (MAPK/ERK
kinase). The kinetics of MEK and ERK activation after haginin A
stimulation showed similar patterns. In addition, we examined
cyclic AMP response element binding protein, which is known
to activate the MITF promoter. However, haginin A had no
effects on its phosphorylation level. These results indicate that
haginin A induces the phosphorylation of ERK and Akt/PKB in
a dose-dependent manner.
Effect of PD98059 and LY294002 on melanin synthesis in
Melan-a cells
Since the phosphorylation of ERK and Akt/PKB seemed to
decrease melanin synthesis, we examined whether the ERK
and/or the Akt/PKB signaling pathways were involved in
melanogenesis. Therefore, we investigated melanin synthesis
after treating with PD98059, a selective inhibitor of MEK
that is a specific upstream activator of ERK, to study the
role of ERK in the haginin A-induced inhibition of melanin
production. We also used LY294002, a phosphatidylinositol
3-kinase inhibitor, which blocks the Akt/PKB signaling
pathway. As shown in Figure 7a, melanin synthesis was
clearly induced after treatment with PD98059, but LY294002
promoted melanogenesis less than PD98059. Next, we
wanted to determine whether PD98059 inhibits ERK and
LY294002 inhibits Akt/PKB activation in Melan-a cells, and
indeed PD98059 was found to block ERK signaling in haginin
A-treated cells and in normal cells, indicating that the inhi-
bition of the ERK pathway induces melanin synthesis and
LY294002 also blocks Akt/PKB slightly (Figure 7b). These
results suggest that the ERK and Akt/PKB pathway plays
a critical role in melanogenesis.
Effects of haginin A on UVB-induced hyperpigmentation in
brown guinea-pig skin
The whitening effect of haginin A was examined using a
UVB-induced hyperpigmentation model in brown guinea-
pigs. Figure 8a shows a photograph of the whitening effects
on the guinea-pig dorsal skin. Haginin A was topically
applied to the UV-induced hyperpigmented dorsal skin
areas twice a day for 4 weeks from the day after the last
tanning. A visible decrease in hyperpigmentation was
observed 2 weeks after the treatment with haginin A,
when compared to the vehicle group. The degree of
pigmentation decreased (DL-value) before and 4 weeks after
the application of haginin A was 3.4. In addition, a strongly
visible decrease in hyperpigmentation was observed at 4
weeks after treatment with haginin A compared to the vehicle
control group (Figure 8c).
Haginin A (μM) 0 0.4 0.8 1.6 3.3
Tyrosinase
TRP-1
TRP-2
β-Actin
Figure 4. Haginin A attenuates the levels of tyrosinase and TRP-1 but has
no effect on TRP-2. Melan-a cells were treated with 0.4–3.3 mM of haginin A
for 4 days. Whole-cell lysates were then subjected to western blot analysis
using antibodies against tyrosinase, TRP-1, and TRP-2. Equal protein
loadings were confirmed using anti-actin antibody.
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Figure 5. Effects of MITF gene expression by haginin A in Melan-a cells.
(a) Inhibition of MITF protein expression by haginin A. Melan-a cells were
treated with the indicated concentrations of haginin A. Whole-cell lysates
were subjected to western blot analysis using MITF. Equal protein loadings
were confirmed using anti-actin antibody. (b) The effects of haginin A on
the MITF mRNA level with indicated concentrations of haginin A. Total
RNA was isolated from the cells, and the cDNA was prepared. Equivalent
amounts of cDNA were amplified with primers specific for MITF, and
GAPDH primers were used as a control to ensure the even loading of the
target cDNA. The resulting PCR products were analyzed by agarose gel
electrophoresis.
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Figure 6. Haginin A induces ERK and Akt/PKB phosphorylation by haginin A
in Melan-a cells. The Melan-a cells were treated with the indicated
concentrations of haginin A. Whole-cell lysates were then subjected to
western blot analysis using antibodies against phospho-specific ERK
(p-ERK), phospho-specific MEK (p-MEK), phospho-specific Akt (p-Akt), and
phospho-specific cyclic AMP response element binding protein (p-CREB).
Equal protein loading was confirmed by reaction with actin, phosphorylation-
independent ERK, Akt, MEK antibodies.
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Effects of haginin A on tyrosinase activity in zebrafish
Phenotype-based evaluation of candidate compounds gives
robust and reliable data for a further experiment. Zebrafish
has melanin pigments on the surface, allowing simple
observation on the pigmentation process without compli-
cated experimental procedures.
Therefore, we investigated the effects of haginin A on
the pigmentation of zebrafish. As a positive control, we
used PTU, a sulfur-containing tyrosinase inhibitor, which is
used widely in zebrafish research (Elsalini and Rohr, 2003).
As shown in Figure 9a, 4 mM haginin A produced remark-
able inhibition on the body pigmentation. Also, we measured
the tyrosinase activity using the whole extract of zebrafish.
There was a substantial decrease in tyrosinase activity after
treatment with haginin A. As expected, haginin A remarkably
decreased tyrosinase activity, similar to PTU (Figure 9c).
DISCUSSION
Haginin A was isolated initially in 1980, as a metabolite of
L. cyrtobotrya (Toshio et al., 1980). The Lespedeza species
(Leguminosae) are known to produce a number of unique
isoflavonoids, and have also been determined to possess
antioxidant activity (Miyase et al., 1999). However, little
is known about biological activities of 7,40-dihydroxy-20,
30-dimethoxyisoflavene, which is also commonly referred to
as haginin A. In this study, we found that haginin A inhibits
mushroom tyrosinase activity in a noncompetitive inhibitory
manner with the same Km value.
Melanogenesis is a major function of melanocytes. To
investigate the effect of haginin A on melanin production, we
treated melanocytes with haginin A and observed a dramatic
inhibition of melanin content upon increasing the concentra-
tion of haginin A in the culture medium. We then compared the
effects of haginin A with those of PTU and kojic acid as positive
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Figure 7. Effects of PD98059 and LY294002 by haginin A on melanogenesis
in Melan-a cells. Cells were pretreated with 20 mM of PD98059 for 1 hour and
then cultured with 3.3 mM of haginin A for 4 days. (a) Melanin content was
measured as described in Materials and Methods. Each column shows the
mean±SD of triplicate determinations. (b) Cells were cultured with 3.3mM of
haginin A in the absence or presence of 20 mM PD98059 and LY294002.
Whole-cell lysates were then subjected to western blot analysis with
antibodies against phospho-specific ERK (p-ERK) and phospho-specific
Akt (p-Akt). Equal protein loading was confirmed by reaction with actin
and phosphorylation-independent ERK, Akt antibodies.
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Figure 8. Effect of haginin A on UVB-induced hyperpigmentation in
guinea-pig skin. (a–c) Representative photographs showing the lightening
effects of haginin A on UVB-induced hyperpigmentation; all photographs are
from the same animal ((a) initial pigmentation after UV irradiation but before
the application of haginin A, (b) 2 weeks, (c) 4 weeks). The vehicle did not
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after the daily topical applications of the vehicle and haginin A. (e) The
degree of pigmentation (DL-value) before and 4 weeks after daily topical
applications of the vehicle and haginin A. The data are expressed as a
mean DL-value±SD. The DL-value was measured using a chromameter.
Groups of four animals were used in this experiment.
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controls in these trials because of their known inhibitory
effects on melanin synthesis (Mishima et al., 1988; Elsalini and
Rohr, 2003). Our results show that the inhibitory effect of
haginin A on melanin was stronger than that of kojic acid.
To study the action of haginin A on melanogenesis, we
investigated the effect of haginin A on tyrosinase activity.
Haginin A significantly inhibits tyrosinase activity in a dose-
dependent manner; this effect of haginin A was stronger than
that of kojic acid. These results suggest that the decreased
melanogenesis by haginin A could be achieved by its
inhibitory action upon the signaling pathway regulating
tyrosinase activity.
In this study, we investigated whether haginin A exerts
hypopigmentary effects in Melan-a cells, and determined that
haginin A potently induced the downregulation of melanin
synthesis in these cells, ostensibly by virtue of an elicited
reduction in the production of tyrosinase. Therefore, we
surmise that reduced tyrosinase activity may be responsible
for the low pigment content observed in cells treated with
haginin A. This suggests that the reduced pigmentation seen
with haginin A treatment is probably attributable to the effects
of haginin A on the signaling pathways responsible for the
regulation of tyrosinase.
Furthermore, our results show that haginin A reduced
MITF protein levels. According to a recent study, it has been
demonstrated that the phosphorylation of MITF at serine 73 is
responsible for MITF ubiquitination and degradation. Also, it
has been demonstrated that the inhibition of the ERK pathway
by a specific inhibitor, PD98059, increased melanin synthesis
(Englaro et al., 1998). These findings suggest that sustained
ERK activation can suppress melanogenesis via increased
MITF degradation, which is induced by ERK-dependent MITF
phosphorylation (Busca and Ballotti, 2000).
Previous studies have shown that ERK activation is related
to cyclic AMP-induced melanogenesis in B16 melanoma
cells (Englaro et al., 1995). Our findings support the notion
that the inhibition of the ERK pathway induces melanin
synthesis; that is, ERK pathway activation may be responsible
for the observed inhibition of melanogenesis by haginin A. In
our experiments, haginin A obviously stimulated the phos-
phorylation of ERK and inhibited the synthesis of melanin
in Melan-a cells. Therefore, the activation of the ERK signal-
ing pathway might perform an important function in the
regulation of melanogenesis and also in the proliferation of
Melan-a cells.
In our study, we have shown that haginin A induced ERK
phosphorylation and reduced melanin synthesis. Recently,
Akt/PKB activation occurs via a pathway that includes phos-
phatidylinositol 3-kinase (Downward, 1998). Interestingly,
Akt/PKB was stimulated at a later stage by haginin A in
Melan-a cells. Many types of neuronal cells are known
to depend on the phosphatidylinositol 3-kinase/Akt kinase
pathway as a crucial growth-promoting and an antiapoptotic
signal (Zhou et al., 1998). Since melanocytes are derived
from the neuroectoderm, it is possible that the Akt/PKB kinase
pathway also plays an important role in melanocyte
proliferation. Earlier studies have shown that the activation
of Akt/PKB is responsible for the suppression of melanin
production in G361 melanoma cells (Oka et al., 2000)
and that the specific inhibition of the Akt/PKB pathway by
LY294002 stimulates melanin synthesis in B16 melanoma
cells (Busca et al., 1996). Here, we showed that haginin A
induced Akt/PKB phosphorylation and inhibited melanin
synthesis. Therefore, we expected that signal transduction
through Akt/PKB could be related to a decrease in the
melanin content. In our study, LY294002 treatment increased
melanin synthesis in Melan-a cells. Thus, our findings are
in agreement with previous studies, which showed that
the Akt/PKB pathway might be involved in the melano-
genesis of melanocytes. Moreover, PD98059 treatment,
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Figure 9. Effects of haginin A on melanogenesis in zebrafish.
(a–d) Representative photographs of zebrafish. Synchronized embryos were
treated with melanogenic inhibitors as the indicated concentrations.
The compounds were dissolved in 0.1% DMSO, then added to the embryo
medium. The effects on the pigmentation of zebrafish were observed under
the stereomicroscope ((a) untreated zebrafish embryo, (b) 0.2mM PTU,
(c) 2 mM haginin A, (d) 4 mM haginin A). (e) Melanin pigment. About
100 embryos were collected and dissolved in lysis buffer. After centrifugation,
melanin pigment (upper panel) was redissolved in 1 N NaOH (lower panel).
(f) Tyrosinase activity. For measurement of tyrosinase activity, 250mg of
total protein was incubated with L-DOPA (final 0.5mM), and then quantified
using a spectrometer. The results are shown as a percentage of control.
All experiments were repeated three times.
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which blocked ERK activation, increased melanin syn-
thesis more than LY294002 treatment in Melan-a cells. In
addition, the results of this study showed ERK and Akt/PKB
activation by haginin A in a dose-dependent manner.
Therefore, we suggest that ERK activation may cause MITF
reduction, and this ultimately results in reduced melanin
synthesis.
Furthermore, we observed efficient lightening effects
following the topical application of haginin A to the dorsal
skin of brownish guinea-pigs in which hyperpigmentation
had been induced by exposure to UVB. This suggests that the
lightening effects exerted by haginin A on UVB-induced
hyperpigmentation may be attributable to the inhibition of
melanin production in active melanocytes.
In addition, we investigated the effects of haginin A on the
pigmentation of zebrafish. Zebrafish is a highly advantageous
vertebrate model organism, because of its similar organ
systems and gene sequences to human beings (Love et al.,
2004). In this study, haginin A decreased the body
pigmentation and the tyrosinase activity.
One interesting finding of this study involves the
consensus between the results obtained from in vivo and
in vitro experiments. Haginin A was determined to be
effective with regard to the amelioration and reversal of
UVB-induced hyperpigmentation and zebrafish in vivo, and
was also determined to effectively inhibit the production
of melanin in vitro.
In summary, we have been generally successful in our
attempt to characterize the hypopigmentary effects exerted
by haginin A, as well as the mechanisms responsible for
these effects. In this study, we report that the inhibitory
effects on tyrosinase activity by haginin A isolated from the
L. cyrtobotrya branch were more pronounced than those
seen with kojic acid. Compounded with the fact that haginin
A exhibited no cytotoxic activity in our study, it can be
surmised that haginin A may prove quite useful as a natural
depigmentation agent. Our findings also suggest that haginin
A exerts an inhibitory effect on melanogenesis in Melan-a
cells via downregulation of MITF and phosphorylation of ERK
and Akt/PKB, which ultimately results in the inhibition of
tyrosinase production. Furthermore, our findings indicate that
haginin A can inhibit the synthesis of melanin via a unique
dual-action mechanism. If this is the case, haginin A might
have significant therapeutic value in terms of the prevention
or treatment of hyperpigmentation. To further delineate
the structure–activity relationships inherent to the chemical,
we are attempting to synthesize haginin A with a range of
haginin A derivatives, and intend to further examine the
skin-whitening effects of haginin A and its derivatives in an
animal model.
MATERIALS AND METHODS
Materials
Mushroom tyrosinase, L-tyrosine, L-DOPA, 12-o-tetradecanoylphorbol-
13-acetate, and PTU were all purchased from Sigma Chemical
Co. (St Louis, MO). The plastics used in the tissue culture were
purchased from Falcon (Becton Dickinson, Franklin Lakes, NJ), and the
media and additives were obtained from Gibco (Grand Island, NY).
Extraction and isolation of haginin A
Haginin A used in this study was isolated from L. cyrtobotrya. In brief,
air-dried L. cyrtobotrya (1 kg) was percolated with MeOH at 25 1C for
3 weeks. The residue obtained after the removal of the solvent (4 g)
was diluted with H2O (500ml) and extracted using EtOAc (500ml
 3). The extract left a dark syrup (1g) upon concentration, and this
was purified via Sephadex LH-20 column chromatography using a
solvent system consisting of MeOH and H2O (8:2). The final
purification was accomplished via HPLC (C18 column) with a 30%
aqueous acetonitrile (YMC-ODS-AM 250 6mm, 10mm; the flow
rate, 1.5mlminute1; detection, UV at 220nm) solvent system. On
the basis of the results of electron spray ionization–mass spectrometry,
1H-NMR (nuclear magnetic resonance), and 13C-NMR spectral data,
the purified compound was identified as haginin A (C17H16O5;
molecular weight 300.10kDa) (Toshio et al., 1980).
Tyrosinase activity
Tyrosinase activity in Melan-a cells was determined as described
previously (Busca et al., 1996), with a slight modification (Park et al.,
2004). In brief, Melan-a cells were cultured in six-well plates. After
incubated with the test substances for 4 days, the cells were washed
in ice-cold phosphate-buffered saline and lysed with phosphate
buffer (pH 6.8) containing 1% Triton X-100. The lysates were
clarified by centrifugation for 5minutes at 10,000 g. After the
quantification of protein levels and the adjustment of concentrations
using lysis buffer, 90ml of each lysate, contained identical amounts
of protein, was placed into each 96-well plate, and 10 ml of 15mM L-
DOPA was added per well. After incubation at 37 1C, we measured
absorbance every 10minutes, for at least 1 hour, at a wavelength of
475 nm, using an ELISA reader. A cell-free assay system was used to
test for the direct effects of haginin A on tyrosinase activity. The
reaction mixture for the determination of mushroom tyrosinase (EC
1.14.18.1) activity contained 150 ml of 0.1M phosphate buffer (pH
6.5), 3 ml of sample solution, 8ml of mushroom tyrosinase
(2,100Uml1, 0.05 M phosphate buffer, pH 6.5), and 36 ml of
1.5mM L-tyrosine in a 96-well microplate (SPL, Pocheon, Korea).
Following incubation at 37 1C, absorbance was measured at 490 nm
using a microplate reader (Bio-Rad 3550; Bio-Rad, Hercules, CA).
Kinetic analysis of tyrosinase inhibition by haginin A
Using various L-tyrosine concentrations as a substrate, we added
mushroom tyrosinase (2,100Uml1) and 0.1M phosphate buffer (pH
6.5), either with or without a test sample to 96-well plates in a total
volume of 200ml as assay mixtures. The initial rate with dopachrome
formed from the reaction mixture was determined as the increase of
absorbance at a wavelength 490nmminute1, using a Powerwave X340
microplate reader (Bio-TEK Instrument Inc., Winooski, VT). The Km and
Vmax values of the tyrosinase activity were assessed via Lineweaver–Burk
plot, using the various concentrations of L-tyrosine substrate.
Cell cultures
All described protocols approved and monitored by the Kubt Institutional
Review Board, in accordance with the Declaration of Helsinki Principles.
Melan-a cell (murine Melan-a melanocyte) is originally derived
from C57BL/6 J (black, a/a) mice, a kind gift from Professor Dorothy C.
Bennett (St George’s Hospital Medical School, London, UK). This
cell line was cultured in RPMI 1640 supplemented with 10% fetal
bovine serum, streptomycin–penicillin (100mgml1 each), and 200nM
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12-o-tetradecanoylphorbol-13-acetate at 37 1C in an atmosphere contai-
ning 5% CO2. Human epidermal melanocytes, also referred to as HEMn,
were obtained by permission according to the Declaration of Helsinki
Principles and supplied by Cascade Biologics Inc. (Portland, OR) and
were grown in Medium 154 (Cascade Biologics Inc.) supplemented with
human melanocyte growth supplement (Cascade Biologics Inc.), 200nM
12-o-tetradecanoylphorbol-13-acetate, and a-melanocyte-stimulating
hormone (1 106M) at 37 1C in an atmosphere containing 5% CO2.
Monolayers of confluent melanocytes were harvested with a mixture of
0.05% trypsin and 0.53mM EDTA (Gibco BRL).
Cell viability assay
Cell viability was determined via crystal violet staining. After 4 days
of incubation with the test substances, the culture medium was
removed and replaced with 0.1% crystal violet in 10% ethanol. The
cells were then stained for a further 5minutes at room temperature,
and then rinsed three times. The crystal violet retained by the
adherent cells was extracted using 95% ethanol, and absorbance
was determined at a wavelength of 590 nm.
Inhibitory effect of melanin production in S. bikiniensis
A preserved culture of S. bikiniensis NRRL B-1049 was inoculated
into a Papavizas’ VDYA agar slant, containing 200ml of V-8 juice
(Campbell Soup Co., Camden, NJ), 2 g of glucose, 2 g of yeast extract
(Difco, Sparks, MD), 1g of CaCO3, 20g of agar (Difco), and 800ml of
distilled water, adjusting the pH to 7.2. After 2 weeks of incubation
at 28 1C, the spore suspension obtained was then transferred to a
series of sterile microtubes. A volume of 0.4ml of the suspension
of S. bikiniensis spores was then added to agar medium ISP no.
7 (40ml), which had been supplemented with 0.2% Bacto-yeast
extract (Difco), and was spread over the surface of the agar uniformly
with a glass hockey bar. After the surface of the agar had dried,
a paper disc (8mm diameter) soaked with the sample solution was
positioned on the agar plate. The plate was incubated at 28 1C for
48 hours; the zone of melanin formation was measured as diameter
(mm) from the reverse side of the plate (Lee et al., 1997).
Measurement of melanin content
The cells were seeded in a 24-well plate (Falcon) at a density of
1 105 cells per well and were allowed to attach overnight. Then
the cells were incubated in a fresh medium containing various
concentrations of compounds for 4 days. After the cells had been
washed with phosphate-buffered saline, they were lysed with 250ml
of 0.85 N KOH and transferred to a 96-well plate. The melanin
contents were estimated via the measurement of absorbance at a
wavelength of 405 nm (Bennett et al., 1987).
Western blot analysis
Cells were lysed in cold lysis buffer (0.1 M Tris–HCl, pH 7.2, 1%
Nonidet P-40, 0.01% SDS, 1mM phenylmethylsulfonyl fluoride,
10 mgml1 leupeptin, 1mgml1 aprotinin). A 30 mg portion of
proteins was separated via 8% SDS-PAGE and blotted onto
polyvinylidene difluoride membrane (Millipore, Bedford, MA). The
membranes were blocked with 5% non-fat skim milk in a Tris-
buffered saline-T buffer. Tyrosinase, TRP-1, TRP-2, and b-actin were
all detected with a rabbit polyclonal anti-aPEP7 antibody, a rabbit
polyclonal anti-aPEP1 antibody, a rabbit polyclonal anti-aPEP8
antibody (a gift from Dr VJ Hearing at National Institutes of Health,
Bethesda, MD) and a mouse monoclonal anti-b-actin antibody
(Sigma), respectively. Phospho-specific ERK1/2, and both phos-
phorylated and non-phosphorylated ERK1/2 were acquired from Cell
Signaling Technology (Beverly, MA), and microphthalmia Ab-1 was
obtained from NeoMarkers (Fremont, CA). The cells were further
incubated with horseradish peroxidase-conjugated secondary anti-
body. All bound antibodies were then detected with an Amersham
ECL system (Amersham Pharmacia Biotech, Piscataway, NJ).
RT-PCR
Total RNA was isolated from cells using an RNease Mini Kit (Qiagen,
Valencia, CA). Then, 1mg of RNA was reverse transcribed using the
ImProm II Reverse Transcription System (Promega, Madison, WI).
The cDNA obtained was amplified with the following primers: MITF
(366 bp product) forward 50-TCCGTCTCTCACTGGATTGGTG-30 and
reverse 50-CGTGAATGTGTGTTCATGCCTGG-30. The PCR condi-
tions were follows: 30 cycles of 1minute at 94 1C, 1minute at 55 1C,
and finally 1minute at 72 1C, and the resulting PCR products were
visualized by electrophoretic separation on 1.5% agarose gels with
ethidium bromide staining. Specific primers for glyceraldehyde-3-
phosphate dehydrogenase were added as a control.
UVB-induced hyperpigmentation in brown guinea-pigs
UVB-induced hyperpigmentation was induced on the backs of the
brown guinea-pigs weighing approximately 500 g (SLC, Shizuoka,
Japan) using a slight modification of the methods reported by Ando
et al. (1998) and Imokawa et al. (1986). The guinea-pigs were
anesthetized with pentobarbital (30mg kg1), and separate areas
(1 cm diametrical circle) of the back of each animal were exposed to
the UVB radiation (Waldmann UV 800, Herbert Waldmann GmbH,
Philips TL/12 lamp emitting 280–305nm). The total UVB dose was
500mJcm2 per exposure. Groups of four animals were used in the
experiments. The animals were exposed to the UVB radiation once a
week for 3 consecutive weeks. The candidate for the whitening agent
was given the material topically to the hyperpigmented areas (1% in
propyleneglycol/EtOH/H2O (5:3:2), 5ml per circle) twice a day for 4
weeks from the next day of the last tanning. The degree of
pigmentation was assessed by the L-value measured using a
chromameter (CR-300, Minolta, Tokyo, Japan). The DL-value was
evaluated according to the L-value (brightness index) measured by the
chromameter, as follows: DL¼ L (at each day measured)L (at day 0).
A reduction in the DL-value indicates UVB-induced skin pigmentation.
Origin and maintenance of parental fish
Adult zebrafishes were obtained from a commercial dealer and
10–15 fishes were kept in 5 l acrylic tank with the following
conditions: 28.5 1C, with a 14/10 hours light/dark cycle. Zebrafishes
were fed three times a day, 6 days per week, with TetraMin
flake food supplemented with live brine shrimps (Artemia salina).
Embryos were obtained from natural spawning that was induced
at the morning by turning on the light. Collection of embryos was
completed within 30minutes (Choi et al., 2007).
Compounds treatment and phenotype-based evaluation and
tyrosinase activity
Synchronized embryos were collected and arrayed by pipette (3–4
embryos per well in 96-well plates containing 200ml of embryo
medium). Test compounds were dissolved in 0.1% DMSO, and then
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added to the embryo medium from 9 to 72 hours post-fertilization
(h.p.f.) (63 hours exposure). The effects on the pigmentation of
zebrafish were observed under the stereomicroscope. Occasional
stirring as well as replacement of the medium was performed daily to
ensure the even distribution of the compounds. In all experiments,
0.2mM PTU was used to generate transparent zebrafish without
interfering in the developmental process (Karlsson et al., 2001), and
considered as a standard positive control. Phenotype-based evalua-
tions of body pigmentation were carried out at 28 and 58 h.p.f. For
observation, embryos were dechorionated by forceps, anesthetized
in tricaine methanesulfonate solution (Sigma), mounted in 3%
methylcellulose on a depression slide (Aquatic Eco-Systems,
Apopka, FL), and photographed under the stereomicroscope MZ16
(Leica Microsystems, Ernst-Leitz-Strasse, Germany). Tyrosinase
activity was spectrometrically determined as described previously
(Busca et al., 1996), with minor modification. Briefly, about 100
zebrafish embryos were treated with melanogenic modulators from
9 to 48 h.p.f. and sonicated in Pro-Prep protein extraction solution
(Intron, Daejeon, Korea). The lysate was clarified by centrifuging at
10,000 g for 5minutes. After quantification, 250 mg of total protein
was added followed by 100 ml of 1mM L-DOPA. Control well
contained 100ml of lysis buffer and 100ml of 1mM L-DOPA. After
incubation for 60minutes at 37 1C, absorbance was measured at
475 nm using the SpectraMax M5 microplate reader (Molecular
Devices Corp., Sunnyvale, CA). All experiments were performed at
least three times with similar results (Choi et al., 2007).
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